RNS Number : 4399Q
Legal & General UCITS ETF PLC
19 June 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
18/06/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
137628416.51 |
11.696 |
| L&G UK Equity UCITS ETF |
18/06/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
11073974.46 |
9.228 |
| L&G Global Equity UCITS ETF |
18/06/2020 |
IE00BFXR5S54 |
2900000 |
USD |
32730517.52 |
11.286 |
| L&G Japan Equity UCITS ETF |
18/06/2020 |
IE00BFXR5T61 |
11085000 |
USD |
118287522.82 |
10.671 |
| L&G Europe ex UK Equity UCITS ETF |
18/06/2020 |
IE00BFXR5V83 |
9260988 |
EUR |
99405790.71 |
10.734 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
18/06/2020 |
IE00BFXR5W90 |
4505639 |
USD |
46509628.88 |
10.323 |
| L&G Clean Water UCITS ETF |
18/06/2020 |
IE00BK5BC891 |
1500000 |
USD |
15519438.82 |
10.346 |
| L&G Artificial Intelligence UCITS ETF |
18/06/2020 |
IE00BK5BCD43 |
6246000 |
USD |
77460218.20 |
12.402 |
| L&G Healthcare Innovation UCITS ETF |
18/06/2020 |
IE00BK5BC677 |
2600000 |
USD |
31833877.14 |
12.244 |
| L&G Pharma Breakthrough UCITS ETF |
18/06/2020 |
IE00BF0H7608 |
2500000 |
USD |
29489381.43 |
11.796 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
18/06/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
93377516.21 |
10.150 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
18/06/2020 |
IE00BKLWY790 |
57400000 |
USD |
602102972.03 |
10.490 |
| L&G Battery Value-Chain UCITS ETF |
18/06/2020 |
IE00BF0M2Z96 |
11750000 |
USD |
109119813.71 |
9.287 |
| L&G Ecommerce Logistics UCITS ETF |
18/06/2020 |
IE00BF0M6N54 |
5500000 |
USD |
58313104.17 |
10.602 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
18/06/2020 |
IE00BMW3QX54 |
47330616 |
USD |
805946174.37 |
17.028 |
| L&G Cyber Security UCITS ETF |
18/06/2020 |
IE00BYPLS672 |
84886776 |
USD |
1579826179.33 |
18.611 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVGZGMVFRKGGZZ
